相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α
Tom van der Wel et al.
JOURNAL OF LIPID RESEARCH (2015)
Cannabinoid receptor with an 'identity crisis' gets a second look
Nala Rogers
NATURE MEDICINE (2015)
Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: From ultrapotent to hyperpotent
Simon Nicolussi et al.
BIOCHEMICAL PHARMACOLOGY (2014)
NIH plans to enhance reproducibility
Francis S. Collins et al.
NATURE (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies
Mauro Maccarrone et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice
Simon Nicolussi et al.
PHARMACOLOGICAL RESEARCH (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
Agnes Poirier et al.
DRUG METABOLISM AND DISPOSITION (2014)
Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2014)
Development of an Activity-Based Probe and In Silico Design Reveal Highly Selective Inhibitors for Diacylglycerol Lipase-α in Brain
Marc P. Baggelaar et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Selective CB2 agonists with anti-pruritic activity: Discovery of potent and orally available bicyclic 2-pyridones
Ken-ichi Kusakabe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action
Erin E. Cawston et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Improved accessibility to the desoxy analogues of Δ9-tetrahydrocannabinol and cannabidiol
Shane M. Wilkinson et al.
TETRAHEDRON LETTERS (2013)
A Continuous, Fluorescence-based Assay of μ-Opioid Receptor Activation in AtT-20 Cells
Alisa Knapman et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7
C. Ullmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Effects of palmitoylation of Cys415 in helix 8 of the CB1 cannabinoid receptor on membrane localization and signalling
Sergio Oddi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bela Horvath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Organotypic liver culture models: Meeting current challenges in toxicity testing
Edward L. LeCluyse et al.
CRITICAL REVIEWS IN TOXICOLOGY (2012)
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
Li Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Decahydroquinoline amides as highly selective CB2 agonists: Role of selectivity on in vivo efficacy in a rodent model of analgesia
Peter J. Manley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
A Randomized, Controlled Study to Investigate the Analgesic Efficacy of Single Doses of the Cannabinoid Receptor-2 Agonist GW842166, Ibuprofen or Placebo in Patients With Acute Pain Following Third Molar Tooth Extraction
Thor Ostenfeld et al.
CLINICAL JOURNAL OF PAIN (2011)
What makes a good drug target?
Isabella Gashaw et al.
DRUG DISCOVERY TODAY (2011)
Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists
Mario van der Stelt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Validation of 96-well Equilibrium Dialysis with Non-radiolabeled Drug for Definitive Measurement of Protein Binding and Application to Clinical Development of Highly-Bound Drugs
Maciej J. Zamek-Gliszczynski et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A(3) adenosine receptor
J. Robert Lane et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: Implications for therapeutics
Natasha L. Grimsey et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Enol Carbamates as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) Endowed with High Selectivity for FAAH over the Other Targets of the Endocannabinoid System
Sonia Gattinoni et al.
CHEMMEDCHEM (2010)
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Latest advances in cannabinoid receptor agonists
Ganesh A. Thakur et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
Fabrizio Montecucco et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
In vitro pharmacological characterization of AM1241:: a protean agonist at the cannabinoid CB2 receptor?
B. B. Yao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Tricyclic pyrazoles.: 4.: Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2′,4′-dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide
Gabriele Murineddu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Δ9-tetrahydrocannabinol immunochemical studies:: Haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled Δ9-tetrahydrocannabinol
LW Qi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The [35S]GTPγS binding assay:: approaches and applications in pharmacology
C Harrison et al.
LIFE SCIENCES (2003)
The endocannabinoid system in human keratinocytes -: Evidence that anandamide inhibits epidermal differentiation through CB1 receptordependent inhibition of protein kinase C, activating protein-1, and transglutaminase
M Maccarrone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Selection criteria for drug-like compounds
I Muegge
MEDICINAL RESEARCH REVIEWS (2003)
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
MJ Banker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Tricyclic pyrazoles.: part 1:: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors
JM Mussinu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
分享论文
